Mymedicure Pharma & Chemical Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
About Mymedicure Pharma & Chemical
Mymedicure Pharma & Chemical Private Limited (MPCPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 March 2021 (Three years and ten months 24 days old ). Its registered office is in Dhule, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jitendrasing Girase, Mayur Girase, and Anil Rajput serve as directors at the Company.
Company Details
-
Location
Dhule, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299MH2021PTC356821
-
Company No.
356821
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Mar 2021
-
Date of AGM
18 Sep 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Mymedicure Pharma & Chemical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jitendrasing Girase
|
Director | 11-Mar-2021 | Current |
|
Mayur Girase
|
Director | 11-Mar-2021 | Current |
|
Anil Rajput
|
Director | 11-Mar-2021 | Current |
Financial Performance of Mymedicure Pharma & Chemical.
Enhance accessibility to Mymedicure Pharma & Chemical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mymedicure Pharma & Chemical?
Unlock access to Mymedicure Pharma & Chemical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Bioquilant Pharma Private LimitedJitendrasing Girase is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mymedicure Pharma & Chemical?
Mymedicure Pharma & Chemical has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mymedicure Pharma & Chemical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mymedicure Pharma & Chemical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.